Medtronic | Des Atouts



Assets Changement Date
Abbott USD 81.41B 7.06B 2024-12
AtriCure USD 609.33M 5.74M 2024-12
Baxter International USD 25.78B 894M 2024-12
Becton, Dickinson and Co. USD 54.67B 2.62B 2024-12
Boston Scientific USD 39.4B 1.32B 2024-12
Cooper Companies USD 12.22B 93M 2025-01
Danaher USD 77.54B 3.07B 2024-12
Dexcom USD 6.48B 130.7M 2024-12
Edwards Lifesciences USD 13.06B 84.1M 2024-12
Globus Medical USD 5.25B 165.71M 2024-12
Hologic USD 8.73B 427.3M 2024-12
Insulet USD 3.09B 62.3M 2024-12
Integra LifeSciences USD 4.04B 28.38M 2024-12
Intuitive Surgical USD 18.74B 999.8M 2024-12
J&J USD 180.1B 1.82B 2024-12
Masimo USD 2.63B 462.1M 2024-12
Medtronic USD 89.97B 69M 2025-01
Merit Medical Systems USD 2.42B 40.52M 2024-12
Philips EUR 28.98B 498M 2024-12
Smith & Nephew USD 10.35B 188M 2024-12
Stryker USD 42.97B 862M 2024-12
Tandem Diabetes Care USD 967.66M 9.93M 2024-12
Teleflex USD 7.1B 388.38M 2024-12
Terumo JPY 1.88T 125.37B 2024-12
Thermo Fisher Scientific USD 97.32B 3.04B 2024-12
Zimmer Biomet Holdings USD 21.37B 355M 2024-12



Medtronic Des Atouts - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2025.